Centre for Chiropractic Research, New Zealand College of Chiropractic, Auckland 1060, New Zealand.
Faculty of Health & Environmental Sciences, Health & Rehabilitation Research Institute, AUT University, Auckland 0627, New Zealand.
Medicina (Kaunas). 2021 May 27;57(6):536. doi: 10.3390/medicina57060536.
The current COVID-19 pandemic has necessitated the need to find healthcare solutions that boost or support immunity. There is some evidence that high-velocity, low-amplitude (HVLA) controlled vertebral thrusts have the potential to modulate immune mediators. However, the mechanisms of the link between HVLA controlled vertebral thrusts and neuroimmune function and the associated potential clinical implications are less clear. This review aims to elucidate the underlying mechanisms that can explain the HVLA controlled vertebral thrust--neuroimmune link and discuss what this link implies for clinical practice and future research needs. A search for relevant articles published up until April 2021 was undertaken. Twenty-three published papers were found that explored the impact of HVLA controlled vertebral thrusts on neuroimmune markers, of which eighteen found a significant effect. These basic science studies show that HVLA controlled vertebral thrust influence the levels of immune mediators in the body, including neuropeptides, inflammatory markers, and endocrine markers. This narravtive review discusses the most likely mechanisms for how HVLA controlled vertebral thrusts could impact these immune markers. The mechanisms are most likely due to the known changes in proprioceptive processing that occur within the central nervous system (CNS), in particular within the prefrontal cortex, following HVLA spinal thrusts. The prefrontal cortex is involved in the regulation of the autonomic nervous system, the hypothalamic-pituitary-adrenal axis and the immune system. Bi-directional neuro-immune interactions are affected by emotional or pain-related stress. Stress-induced sympathetic nervous system activity also alters vertebral motor control. Therefore, there are biologically plausible direct and indirect mechanisms that link HVLA controlled vertebral thrusts to the immune system, suggesting HVLA controlled vertebral thrusts have the potential to modulate immune function. However, it is not yet known whether HVLA controlled vertebral thrusts have a clinically relevant impact on immunity. Further research is needed to explore the clinical impact of HVLA controlled vertebral thrusts on immune function.
当前的 COVID-19 大流行需要寻找能够增强或支持免疫力的医疗保健解决方案。有一些证据表明,高速、低振幅(HVLA)控制的椎体推力有可能调节免疫介质。然而,HVLA 控制的椎体推力与神经免疫功能之间的联系的机制以及相关的潜在临床意义尚不清楚。本综述旨在阐明可以解释 HVLA 控制的椎体推力-神经免疫联系的潜在机制,并讨论这一联系对临床实践和未来研究需求的意义。对截至 2021 年 4 月发表的相关文章进行了搜索。共发现了 23 篇探讨 HVLA 控制的椎体推力对神经免疫标志物影响的已发表论文,其中 18 篇发现了显著影响。这些基础科学研究表明,HVLA 控制的椎体推力会影响体内免疫介质的水平,包括神经肽、炎症标志物和内分泌标志物。本综述讨论了 HVLA 控制的椎体推力可能影响这些免疫标志物的最可能机制。这些机制很可能是由于在 HVLA 脊柱推力后,中枢神经系统(CNS)内特别是前额叶皮层内发生的本体感受处理的已知变化所致。前额叶皮层参与自主神经系统、下丘脑-垂体-肾上腺轴和免疫系统的调节。双向神经免疫相互作用受情绪或与疼痛相关的应激影响。应激引起的交感神经系统活动也会改变椎体运动控制。因此,有生物学上合理的直接和间接机制将 HVLA 控制的椎体推力与免疫系统联系起来,这表明 HVLA 控制的椎体推力有可能调节免疫功能。然而,目前尚不清楚 HVLA 控制的椎体推力对免疫功能是否具有临床相关影响。需要进一步研究来探索 HVLA 控制的椎体推力对免疫功能的临床影响。